Orrum’s CŌRE Insights™ analytics platform will be available through an automatic integration for LivaNova’s Essenz Perfusion System PLYMOUTH, Mich., Feb. 20, 2026Orrum’s CŌRE Insights™ analytics platform will be available through an automatic integration for LivaNova’s Essenz Perfusion System PLYMOUTH, Mich., Feb. 20, 2026

Orrum Announces Strategic Partnership with LivaNova to Unite Intelligent Data with Innovative Perfusion Technology

2026/02/20 21:32
Okuma süresi: 3 dk

Orrum’s CŌRE Insights™ analytics platform will be available through an automatic integration for LivaNova’s Essenz Perfusion System

PLYMOUTH, Mich., Feb. 20, 2026 /PRNewswire/ — Orrum Clinical Analytics today announced a strategic partnership with LivaNova USA Inc. to connect LivaNova’s Essenz™ Perfusion System to the analytics and benchmarking capabilities of Orrum’s CŌRE Insights™ platform.

Designed for patient management during cardiopulmonary bypass, the Essenz Perfusion System (Essenz) features advanced tools to support data-driven care, including Quality Indicators and Goal-Directed Perfusion. Through this strategic partnership, Orrum and LivaNova are introducing CoreInsights for Essenz, empowering clinicians to make more confident decisions, while advancing safety, quality, and data literacy across perfusion and extracorporeal care.

Through this collaboration, perfusion case data from the Essenz database can be safely and automatically transferred to Orrum’s analytics platform for post-operative analysis and peer benchmarking, supporting evidence-based performance improvement. Through this integration, CoreInsights for Essenz can extend the value of perfusion data beyond the operating room, supporting meaningful pre- and post-operative analytics across the full patient care continuum.

Built within a secure, legally privileged Patient Safety Organization (PSO) recognized by the U.S. Department of Health & Human Services, Orrum’s platform integrates curated advanced data visualizations, powerful analytics, peer benchmarking, and non-routine safety event reporting to deliver actionable insights that clinicians can trust.

CoreInsights for Essenz can provide perfusion teams with:

  • Automatic, continuous data capture and submission for improved accuracy and workflow
  • Curated, clinically relevant analytics to measure adherence to hospital and national benchmarks
  • Actionable, timely insights for perfusionists on practice patterns and key performance indicators

“Our collaboration with LivaNova is rooted in a shared objective: empowering clinicians, elevating patient outcomes, and inspiring innovation that reaches far beyond the operating room,” said Sean Murtha, CEO of Orrum. “At our core, Orrum is committed to advancing clinical quality, safety, and excellence. Through this integration, we are transforming clinical data into clear, decision-ready insights and ushering in a new era of analytics in cardiac surgery with CoreInsights for Essenz.”

To learn more, visit orrum.com/core-insights/.

About Orrum Clinical Analytics

Orrum Clinical Analytics is a clinical intelligence hub designed to support how healthcare teams use data to advance quality and safety. Built within a secure, legally privileged Patient Safety Organization (PSO) recognized by the U.S. Department of Health & Human Services, Orrum integrates advanced data visualizations, analytics, peer benchmarking, and non-routine safety event reporting to support higher standards of performance across perfusion and extracorporeal care. For more information, please visit orrum.com.

MEDIA CONTACT:
Sean Murtha / Orrum / 833-313-DATA (3282)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/orrum-announces-strategic-partnership-with-livanova-to-unite-intelligent-data-with-innovative-perfusion-technology-302693084.html

SOURCE Orrum Clinical Analytics

Piyasa Fırsatı
Unite Logosu
Unite Fiyatı(UNITE)
$0.00008857
$0.00008857$0.00008857
-0.21%
USD
Unite (UNITE) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

The Quantum Leap: Preparing for the Next Era of Computational Power

The Quantum Leap: Preparing for the Next Era of Computational Power

While Artificial Intelligence dominated the headlines of the early 2020s, a more fundamental revolution was brewing in the world of Technology: Quantum Computing
Paylaş
Techbullion2026/02/21 05:48
Hadron Labs Launches Bitcoin Summer on Neutron, Offering 5–10% BTC Yield

Hadron Labs Launches Bitcoin Summer on Neutron, Offering 5–10% BTC Yield

Hadron Labs launches 'Bitcoin Summer' on Neutron, BTC vaults for WBTC, eBTC, solvBTC, uniBTC and USDC. Earn 5–10% BTC via maxBTC, with up to 10x looping.
Paylaş
Blockchainreporter2025/09/18 02:00
3 Paradoxes of Altcoin Season in September

3 Paradoxes of Altcoin Season in September

The post 3 Paradoxes of Altcoin Season in September appeared on BitcoinEthereumNews.com. Analyses and data indicate that the crypto market is experiencing its most active altcoin season since early 2025, with many altcoins outperforming Bitcoin. However, behind this excitement lies a paradox. Most retail investors remain uneasy as their portfolios show little to no profit. This article outlines the main reasons behind this situation. Altcoin Market Cap Rises but Dominance Shrinks Sponsored TradingView data shows that the TOTAL3 market cap (excluding BTC and ETH) reached a new high of over $1.1 trillion in September. Yet the share of OTHERS (excluding the top 10) has declined since 2022, now standing at just 8%. OTHERS Dominance And TOTAL3 Capitalization. Source: TradingView. In past cycles, such as 2017 and 2021, TOTAL3 and OTHERS.D rose together. That trend reflected capital flowing not only into large-cap altcoins but also into mid-cap and low-cap ones. The current divergence shows that capital is concentrated in stablecoins and a handful of top-10 altcoins such as SOL, XRP, BNB, DOG, HYPE, and LINK. Smaller altcoins receive far less liquidity, making it hard for their prices to return to levels where investors previously bought. This creates a situation where only a few win while most face losses. Retail investors also tend to diversify across many coins instead of adding size to top altcoins. That explains why many portfolios remain stagnant despite a broader market rally. Sponsored “Position sizing is everything. Many people hold 25–30 tokens at once. A 100x on a token that makes up only 1% of your portfolio won’t meaningfully change your life. It’s better to make a few high-conviction bets than to overdiversify,” analyst The DeFi Investor said. Altcoin Index Surges but Investor Sentiment Remains Cautious The Altcoin Season Index from Blockchain Center now stands at 80 points. This indicates that over 80% of the top 50 altcoins outperformed…
Paylaş
BitcoinEthereumNews2025/09/18 01:43